Last reviewed · How we verify
NCT05745909: LIVELOC
Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy
NA trial testing Laparoscopic or open low-anterior resection of the rectum with TME and created loop transverse colostomy in Rectal Neoplasms in 150 participants. Completed in 30 July 2024.
31 May 2024
Quick facts
| Lead sponsor | Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 March 2023 |
| Primary completion | 31 May 2024 |
| Estimated completion | 30 July 2024 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Laparoscopic or open low-anterior resection of the rectum with TME and created loop transverse colostomy
- Laparoscopic or open low-anterior resection of the rectum with TME and created loop ileostomy
Conditions studied
- Rectal Neoplasms — all drugs for Rectal Neoplasms →
- Ostomy — all drugs for Ostomy →
- Neoplasms — all drugs for Neoplasms →
Sponsor
Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan
Who can join
Adults 18 to 79, any sex, with Rectal Neoplasms or Ostomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine which stoma creation technique is preferable after low anterior resection of the rectum.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05745909
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rectal Neoplasms
Currently open trials in the same condition.
- NCT07522294 — Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision · NA · active not recruiting
- NCT07154173 — Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer · recruiting
- NCT06442215 — Selection of Surgical Technique in Rectal Cancer · recruiting
- NCT06017583 — Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer · Phase 3 · recruiting
- NCT05943444 — Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05745909 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05745909.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing